{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antigen[C268]|Rotavirus Antigen" in comments (approximate match)
Showing 1 - 6 of 6 results
Status:
US Approved Rx
(2008)
First approved in 2008
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02542462: Phase 4 Interventional Completed Intussusception
(2015)
Source URL:
First approved in 2006
Source:
BLA125122
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02542462: Phase 4 Interventional Completed Intussusception
(2015)
Source URL:
First approved in 2006
Source:
BLA125122
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02542462: Phase 4 Interventional Completed Intussusception
(2015)
Source URL:
First approved in 2006
Source:
BLA125122
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02542462: Phase 4 Interventional Completed Intussusception
(2015)
Source URL:
First approved in 2006
Source:
BLA125122
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02542462: Phase 4 Interventional Completed Intussusception
(2015)
Source URL:
First approved in 2006
Source:
BLA125122
Source URL:
Class:
STRUCTURALLY DIVERSE